Hikma Pharmaceuticals USA Inc
Insulin normally suppresses gluconeogenesis while promoting lipogenesis, however, under insulin resistant states such as T2D, hepatic lipogenesis remains insulin sensitive and suppression of gluconeogenesis is insulin resistant, leading to a metabolic state called selective hepatic insulin resistance (199)
However, because it influences metabolic pathways, its essential to approach its use cautiously
Some independent researchers recommend taking the full daily dose on an empty stomach, first thing in the morning
One of our licensed providers will briefly review your wellness goals and health history
Research has demonstrated that through its unique mechanism of action involving beta-3 adrenergic receptor modulation and direct interaction with adipose tissue, this peptide offers a scientifically-supported approach to metabolic support and fat oxidation enhancement